Company Filing History:

20 out of 1,829

Schering Corporation

Intervet International B.v.

patents

where one patent can have more than one assignee

Years Active: 1977-2012

Loading Chart...

21 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8236805 - [object Object] (2012-08-07),

2. 7700597 - Substituted piperazines as CB1 antagonists (2010-04-20),

3. 6740661 - Farnesyl protein transferase inhibitors (2004-05-25),

4. 6440989 - Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase (2002-08-27),

5. 6218401 - Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase (2001-04-17),

6. 6130229 - Tricyclic compounds having activity as RAS-FPT inhibitors (2000-10-10),

7. 5942522 - Antiviral compounds and antihypertensive compounds (1999-08-24),

8. 5412104 - Ester and alkoxy substituted benzopyrans (1995-05-02),

9. 5382572 - Alkyl and acyl substituted quinolines (1995-01-17),

10. 5378694 - Acyl and alkoxy substituted quinolines (1995-01-03),

11. 5238950 - Inhibitors of platelet-derived growth factor (1993-08-24),

12. 5190956 - Certain N-substituted 3-oximino-2,4-dioxoquinolin-2,4-(1H)diones useful (1993-03-02),

13. 5179107 - Antiviral quinolinone compounds (1993-01-12),

14. 5179093 - Quinoline-diones (1993-01-12),

15. 5175151 - Antiviral compounds and antihypertensive compounds (1992-12-29),

Title: The Innovative Contributions of Jay Weinstein: A Profile

Introduction: Jay Weinstein, based in Upper Montclair, NJ, is a prolific inventor with a total of 21 patents to his name. His work has significantly impacted various fields, particularly in the development of compounds that address critical health issues. His latest patents showcase his commitment to creating solutions for conditions that affect a broad population.

Latest Patents: Among his latest innovations are compounds of Formula (I), which include substituted piperazines acting as CB1 antagonists. These compounds and their pharmaceutically acceptable salts, solvates, or esters aim to treat diseases mediated by CB receptors. This includes metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders such as psychosis, addiction (for instance, smoking cessation), gastrointestinal disorders, and cardiovascular conditions.

Career Highlights: Jay Weinstein has worked for influential companies such as Schering Corporation and Intervet Inc., where he has had a remarkable influence on drug development and pharmaceutical advancements. His extensive experience in these organizations has shaped his innovative mindset and approach to solving complex medical challenges.

Collaborations: Throughout his career, Jay has collaborated with talented professionals such as Adriano Afonso and Margaret J Gentles. These partnerships have further propelled his work in the pharmaceutical field, allowing for the cross-pollination of ideas and expertise.

Conclusion: Jay Weinstein's contributions to the field of pharmaceuticals and medical inventions demonstrate his dedication to improving human health. With 21 patents and a history of significant collaborations, his innovative spirit continues to inspire and drive advancements that can potentially change patients' lives for the better.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.